drugset / Trial / NCT07578857

Combined Effects of Withania Somnifera & Syzgium Cumini on Hyperlipidemia

NCT07578857

Completed 60 enrolled Riphah International University
RandomizedParallel-groupSingle-blindTreatment

Summary

Withania somnifera and Syzygium cumini are known for their potential therapeutic effects, particularly in managing lipid disorders. This study was aimed to provide valuable insights into their separate and synergistic effect of Withania somnifera (Ashwagandha) and Syzygium cumini (Jamun) on hyperlipidemic patients. The study included 60 patients, equally divided into four groups. Pre- and post-treatment assessments were conducted over 3 months. Each group recieved different treatment. Data was analyzed using SPSS version 21 through paired sample t-test. The findings of the research showed that Withania somnifera showed significant improvement in improving lipid profile and associated factors and concluded that the combination may be an effective and safe approach for managing hyperlipidaemia due to its beneficial impact on lipid profile.

Timeline

Start
2023-05-24
Primary completion
2023-10-10
Completion
2023-10-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Ashwagandha Traditional medicine (herbal / TCM) 1000 mg
Subject Syzygium cumini Unknown 1000 mg

Indications